430 related articles for article (PubMed ID: 26977883)
21. Glycogen synthase kinase-3β ablation limits pancreatitis-induced acinar-to-ductal metaplasia.
Ding L; Liou GY; Schmitt DM; Storz P; Zhang JS; Billadeau DD
J Pathol; 2017 Sep; 243(1):65-77. PubMed ID: 28639695
[TBL] [Abstract][Full Text] [Related]
22. Early requirement of Rac1 in a mouse model of pancreatic cancer.
Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
[TBL] [Abstract][Full Text] [Related]
23. ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis.
Wang L; Yang H; Zamperone A; Diolaiti D; Palmbos PL; Abel EV; Purohit V; Dolgalev I; Rhim AD; Ljungman M; Hadju CH; Halbrook CJ; Bar-Sagi D; di Magliano MP; Crawford HC; Simeone DM
Genes Dev; 2019 Jun; 33(11-12):641-655. PubMed ID: 31048544
[TBL] [Abstract][Full Text] [Related]
24. KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.
Bishehsari F; Zhang L; Barlass U; Preite NZ; Turturro S; Najor MS; Shetuni BB; Zayas JP; Mahdavinia M; Abukhdeir AM; Keshavarzian A
Int J Cancer; 2018 Oct; 143(8):1994-2007. PubMed ID: 29756386
[TBL] [Abstract][Full Text] [Related]
25. GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant
Shen J; Ha DP; Zhu G; Rangel DF; Kobielak A; Gill PS; Groshen S; Dubeau L; Lee AS
Proc Natl Acad Sci U S A; 2017 May; 114(20):E4020-E4029. PubMed ID: 28461470
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic Acinar-to-Ductal Metaplasia and Pancreatic Cancer.
Wang L; Xie D; Wei D
Methods Mol Biol; 2019; 1882():299-308. PubMed ID: 30378064
[TBL] [Abstract][Full Text] [Related]
27. Numb regulates acinar cell dedifferentiation and survival during pancreatic damage and acinar-to-ductal metaplasia.
Greer RL; Staley BK; Liou A; Hebrok M
Gastroenterology; 2013 Nov; 145(5):1088-1097.e8. PubMed ID: 23891977
[TBL] [Abstract][Full Text] [Related]
28. In vivo reprogramming drives Kras-induced cancer development.
Shibata H; Komura S; Yamada Y; Sankoda N; Tanaka A; Ukai T; Kabata M; Sakurai S; Kuze B; Woltjen K; Haga H; Ito Y; Kawaguchi Y; Yamamoto T; Yamada Y
Nat Commun; 2018 May; 9(1):2081. PubMed ID: 29802314
[TBL] [Abstract][Full Text] [Related]
29. PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice.
Wu CY; Carpenter ES; Takeuchi KK; Halbrook CJ; Peverley LV; Bien H; Hall JC; DelGiorno KE; Pal D; Song Y; Shi C; Lin RZ; Crawford HC
Gastroenterology; 2014 Dec; 147(6):1405-16.e7. PubMed ID: 25311989
[TBL] [Abstract][Full Text] [Related]
30. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
[TBL] [Abstract][Full Text] [Related]
31. Lineage Tracing of Primary Human Pancreatic Acinar and Ductal Cells for Studying Acinar-to-Ductal Metaplasia.
Liu J; Wang P
Methods Mol Biol; 2019; 1882():55-62. PubMed ID: 30378043
[TBL] [Abstract][Full Text] [Related]
32. Induction of Pancreatic Inflammation Accelerates Pancreatic Tumorigenesis in Mice.
Zhuang L; Zhan X; Bi Y; Ji B
Methods Mol Biol; 2019; 1882():287-297. PubMed ID: 30378063
[TBL] [Abstract][Full Text] [Related]
33. Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.
Hidalgo-Sastre A; Brodylo RL; Lubeseder-Martellato C; Sipos B; Steiger K; Lee M; von Figura G; Grünwald B; Zhong S; Trajkovic-Arsic M; Neff F; Schmid RM; Siveke JT
Am J Pathol; 2016 Nov; 186(11):2934-2944. PubMed ID: 27639167
[TBL] [Abstract][Full Text] [Related]
34. [New insights into the origin of pancreatic cancer. Role of atypical flat lesions in pancreatic carcinogenesis].
Esposito I; Konukiewitz B; Schlitter AM; Klöppel G
Pathologe; 2012 Nov; 33 Suppl 2():189-93. PubMed ID: 23011021
[TBL] [Abstract][Full Text] [Related]
35. The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male Mice.
Young CC; Baker RM; Howlett CJ; Hryciw T; Herman JE; Higgs D; Gibbons R; Crawford H; Brown A; Pin CL
Cell Mol Gastroenterol Hepatol; 2019; 7(1):93-113. PubMed ID: 30510993
[TBL] [Abstract][Full Text] [Related]
36. Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice.
Salaymeh Y; Farago M; Sebban S; Shalom B; Pikarsky E; Katzav S
Life Sci Alliance; 2020 May; 3(5):. PubMed ID: 32277014
[TBL] [Abstract][Full Text] [Related]
37. Where and when does pancreatic carcinoma start?
Lüttges J; Hahn S; Klöppel G
Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
[TBL] [Abstract][Full Text] [Related]
38. Dicer regulates differentiation and viability during mouse pancreatic cancer initiation.
Morris JP; Greer R; Russ HA; von Figura G; Kim GE; Busch A; Lee J; Hertel KJ; Kim S; McManus M; Hebrok M
PLoS One; 2014; 9(5):e95486. PubMed ID: 24788257
[TBL] [Abstract][Full Text] [Related]
39. Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis.
Carrer A; Trefely S; Zhao S; Campbell SL; Norgard RJ; Schultz KC; Sidoli S; Parris JLD; Affronti HC; Sivanand S; Egolf S; Sela Y; Trizzino M; Gardini A; Garcia BA; Snyder NW; Stanger BZ; Wellen KE
Cancer Discov; 2019 Mar; 9(3):416-435. PubMed ID: 30626590
[TBL] [Abstract][Full Text] [Related]
40. Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics.
Layeghi-Ghalehsoukhteh S; Pal Choudhuri S; Ocal O; Zolghadri Y; Pashkov V; Niederstrasser H; Posner BA; Kantheti HS; Azevedo-Pouly AC; Huang H; Girard L; MacDonald RJ; Brekken RA; Wilkie TM
Sci Rep; 2020 Nov; 10(1):20662. PubMed ID: 33244070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
